Details
Tolevas Indications
- Reduce the risk of myocardial infarction.
- Reducing the risk of stroke.
- Reducing the risk of revascularization procedures and angina.
- Reduce the risk of myocardial infarction.
- Reducing the risk of stroke.
- Reducing the risk of non-lethal myocardial infarction.
- Reduce the risk of lethal and non-lethal stroke.
- Reducing the risk of revascularization procedures.
- Reducing the risk of hospitalization due to congestive heart failure.
- Reducing the risk of strokes.
Contradictions
- Active liver disease, which may include a persistent increase in liver
- Transaminases of unknown etiology.
- Hypersensitivity to any component of this medication.
- Pregnancy. The period of lactation.
Dosage & Administration
Hyperlipidemia (heterozygous familial and non-family) and mixed dyslipidemia (type IIa and IIb Fredrickson classification)
The recommended starting dose is 10 or 20 mg 1 time a day. For patients requiring a significant reduction in LDL-C (over 45%), therapy may be initiated dosing of 40 mg 1 time a day.
Drug dose range is between 10 to 80 mg once daily. The drug can make a one-time dose at any hour and regardless of the meal. Initial and maintenance doses of drug are to be selected individually, depending on the purpose of treatment and response. After the treatment and / or upon titration of the dose should be analyzed lipid levels over a period of 2 to 4 weeks and dosage adjusted accordingly.
